期刊文献+

中国汉族健康人群UGT2B7的基因多态性 被引量:4

Genetic polymorphisms of UGT-glucurono-syltransferase 2B7 in Chinese healthy Han population
原文传递
导出
摘要 目的研究中国汉族健康人UGT2B7基因多态性及其单倍型的分布。方法用聚合酶链式反应和直接测序法,对160名无直接血缘关系的中国汉族健康受试者进行UGT2B7基因多态性检测,用Phase 2.1软件分析单倍型的分布频率。结果在-327 A>G、-161 T>C、802 C>T、2283 A>G和2316 A>G的分布频率均为34.1%,在-125 T>C和211 G>T的分布频率分别为5.26%,16.7%。GCTGGTT、GCTTGTT及ATTGACC单倍型的分布频率较高,分别为48.0%,10.4%,32.6%。结论 -327 A>G、-161 T>C、802 C>T、2283 A>G和2316 A>G在中国汉族健康人群中的分布存在连锁,其分布频率较高;GCTGGTT单倍型的分布频率最高。 Objective To detect the polymorphisms and haplotype of UGT - glucurono - syltransferase 2B7 ( UGT2B7 ) in Chinese healthy Han population. Methods One hundred and sixty Chinese Han healthy volunteers were entrolled in this study. The polymorphisms of UGT2B7 were analyzed by the polymerase chain reaction (PCR) -direct sequen- cing. The haplotype frequencies were analyzed by Phase 2. 1. Results The frequency distribution of UGT2B7 variations in the -327 A 〉 G, - 161 T 〉 C,802 C 〉T,2283 A 〉 G and 2316 A 〉 G was 34. 1% ; in the - 125 T 〉 C, and 211 G 〉 T were 5.26%, 16. 7%, respectively. The frequency distribution of UGT2B7 haplotype of GCTGGTI', GCTTGTI', and ATYGACC were 48.0%, 10. 4%, 32.6%, respectively. Conclu- sion The polymorphisms of -327 A 〉 G, -161 T〉C, 802 C〉T, 2283 A 〉 G and 2316 A 〉 G in UGT2B7 gene were not in linkage dise- quilibrium. The frequency of these variants was high in Chinese healthy Han population. The frequency of GCTGGTI" haplotype was high as well.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2014年第1期6-8,共3页 The Chinese Journal of Clinical Pharmacology
基金 国家自然科学基金青年基金资助项目(81302796) 河南省医学科技攻关计划基金资助项目(201203148)
关键词 基因多态性 聚合酶链式反应 分布频率 单倍型 polymorphism polymerase chain reaction frequency distri- bution haplotype
  • 相关文献

参考文献10

  • 1易娟,谢海棠,周宏灏.UGT1A9 C-2152T和UGT2B7 G211T突变在中国汉族人群中的分布[J].中国临床药理学与治疗学,2007,12(4):460-464. 被引量:9
  • 2Zaya MJ,Hines RN,Stevens JC. Epirubicin glucuronidation and UGT2B7 developmental expression[J].{H}DRUG METABOLISM AND DISPOSITION,2006.2097-2101.
  • 3Abildskov K,Weldy P,Garland M. Molecular cloning of the baboon UDP-glucuronosyltra-nsferase 2B gene family and their activity in conjugating morphine[J].{H}DRUG METABOLISM AND DISPOSITION,2010.545-553.
  • 4Fukuda T,Goebel J,Cox S. UGT1A9,UGT2B7,and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients[J].{H}Therapeutic Drug Monitoring,2012.671-679.
  • 5Innocenti F,Liu W,Fackenthal D. Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene[J].{H}PHARMACOGENETICS AND GENOMICS,2008.683-697.
  • 6Lin GF,Guo WC,Chen JG. An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China[J].{H}Toxicological Sciences,2005.502-506.
  • 7Hwang MS,Lee SJ,Jeong HE. Genetic variations in UDP-glucuronosyltransferase 2B7 gene (UGT2B7) in a Korean population[J].{H}Drug Metabolism and Pharmacokinetics,2010.398-402.
  • 8Saito K,Moriya H,Sawaguchi T. Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects[J].{H}CLINICAL BIOCHEMISTRY,2006.303-308.
  • 9Kwara A,Lartey M,Boamah I. Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients:UGT2B7*1c is associated with faster zidovudine clearance and glucuronidation[J].{H}Journal of Clinical Pharmacology,2009.1079-1090.
  • 10Parmar S,Stingl JC,Huber-Wechselberger A. Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer[J].{H}Breast Cancer Research,2011.57.

二级参考文献13

  • 1Gong QH,Cho JW,Huang T,et al.Thirteen UDP glucuronosyltransferase genes are encoded at the human UGT1 gene complex locus[J].Pharmacogenetics,2001;11:357-368.
  • 2Albert C,Vallee M,Beaudry G,et al.The monkey and human uridine diphosphate glucuronosyltransferase UGT1A9,expressed in steroid target tissues,are estrogen-conjugating enzymes[J].Endocrinology,1999,140:3292-3302.
  • 3Riedy M,Wang JY,Miller AP,et al.Genomic organization of the UGT2b gene cluster on human chromosome 4q13[J].Pharmacogenetics,2000;10:251-260.
  • 4Ritter JK,Sheen YY,Owens IS.Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells.3,4-Catechol estrogens and estriol as primary substrates[J].J Biol Chem,1990;265:7900-7906.
  • 5Coffman BL,Rios GR,King CD,et al.Human UGT2B7 catalyzes morphine[J].Drug Metab Disposl,1997;25:1-4.
  • 6Takeshi H,Ichiro I,Hiroshe T,et al.Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy[J].Drug Metab Dispos,2003;31:677-680.
  • 7Coffman BL,Kearney WR,Green MD,et al.Analysis of opioid binding to UDP-glucurosyltransferase 2B7 fusion proteins using nuclear magnetic resonance spectroscopy[J].Mol Pharmacol,2001;59:1464-1469.
  • 8Sambrook J.Molecular cloning(A laboratory Manual)[M].2nd edition.Cold Spring Harbor Labo.
  • 9Hugo Girarda,Michael H.Courtb,et al.Identification of common polymorphisms in the promoter of the UGT1A9 gene:evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver[J].Pharmacogenetics,2004;14:501-515.
  • 10Strassburg CP,Manns MP,Tukey RH.Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer[J].Cancer Res,1997;57:2979-2985.

共引文献8

同被引文献40

  • 1Mackenzie PI, Bock KW, Burchell B, et al. Nomenclature update for the mammalian UDP glycosyhransferase (UGT) gene superfamily [ J ]. Pharmacogenet Genomics, 2005, 15 : 677 - 685.
  • 2Coffman BL, King CD, Rios GR, et al. The glucuronidation of opioids other xenobiotics and androgens by human UGT'2B7Y (268) and UGT2BTH (268) [J]. DrugMetabDispos, 1998, 26: 73-77.
  • 3Hwang MS, Lee SJ, Jeong HE, et al. Genetic variations in UDP - glucuronosyltransferase 2B7 gene (UGT2B7) in a Korean popula- tion[J]. Drug Metab Pharmacokinet, 2010, 25:398-402.
  • 4Hu DG, Meech R, Lu L, et al. Polymorphisms and haplotypes of the UDP - glucuronosyhransferase 2B7 gene promoter [ J ]. Drug Metab Dispos, 2014, 42:854 - 862.
  • 5Innoeenti F, Liu W, Faekenthal D, et al. Single nueleotide poly-morphism discovery and functional assessment of variation in the UDP - glucuronosyhransferase 2B7 gene [ J ]. Pharmacogenet Ge- nomics, 2008,18 : 683 - 697.
  • 6Inoue K, Suzuki E, Yazawa R, et al. Influence of uridine diphos- phate glueuronosyltransferase 2B7 - 161C > T polymorphism on the concentration of valproie acid in pediatric epilepsy patients [ J ]. Ther Drug Monit, 2014, 36:406-409.
  • 7Bae SK, Jeong YJ, Lee C, et al. Identification of human UGT iso- forms responsible for glueuronidation of efavirenz and its three hy- droxy metabolites[ J]. Xenobiotica, 2011 , 41:437 -444.
  • 8Ma CL, Wu XY, Jiao Z, et al . SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxearbazepine therapy[ J]. Pharmacogenomics, 2015,16 : 347 - 360.
  • 9Yuan L, Qian S, Xiao Y, et al. Homo- and hetero- dimerization of human UDP - glueuranosyltransferase 2B7 ( UGT2B7 ) wild type and its allelie variants affeet zidovudine glueuronidation activity [ J ]. Biochem Pharmaeol. 2015. 95,58 - 70.
  • 10Itiiaho K, Mackenzie PI, Ikushiro S, et al. The configuration of the 17 - hydroxy group variably influences the glucuronidation of beta - estradiol andepiestradiol by human UDP - glucuronosyhransferases [J]. Drug Metab Dispos, 2008, 36:2307 -2315.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部